Ameriprise’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.3M Sell
396,064
-29,918
-7% -$1.08M ﹤0.01% 1561
2025
Q1
$16.8M Sell
425,982
-33,055
-7% -$1.3M ﹤0.01% 1422
2024
Q4
$13.8M Sell
459,037
-335
-0.1% -$10.1K ﹤0.01% 1575
2024
Q3
$10.7M Buy
459,372
+327,029
+247% +$7.65M ﹤0.01% 1721
2024
Q2
$2.35M Buy
132,343
+1,925
+1% +$34.2K ﹤0.01% 2796
2024
Q1
$1.98M Buy
130,418
+3,600
+3% +$54.8K ﹤0.01% 2877
2023
Q4
$2.16M Buy
126,818
+63,760
+101% +$1.08M ﹤0.01% 2832
2023
Q3
$527K Sell
63,058
-8,705
-12% -$72.8K ﹤0.01% 3393
2023
Q2
$1.78M Sell
71,763
-100
-0.1% -$2.48K ﹤0.01% 2930
2023
Q1
$1.08M Buy
+71,863
New +$1.08M ﹤0.01% 3111
2021
Q3
Sell
-5,217
Closed -$203K 3956
2021
Q2
$203K Buy
+5,217
New +$203K ﹤0.01% 3741
2021
Q1
Sell
-3,951
Closed -$206K 3892
2020
Q4
$206K Buy
+3,951
New +$206K ﹤0.01% 3610
2020
Q2
Sell
-30,905
Closed -$304K 3733
2020
Q1
$304K Buy
30,905
+15,847
+105% +$156K ﹤0.01% 3298
2019
Q4
$167K Buy
+15,058
New +$167K ﹤0.01% 3598
2018
Q1
Sell
-95,704
Closed -$785K 3678
2017
Q4
$785K Sell
95,704
-84,947
-47% -$697K ﹤0.01% 3061
2017
Q3
$2.14M Sell
180,651
-96,584
-35% -$1.14M ﹤0.01% 2580
2017
Q2
$2.79M Buy
277,235
+166,434
+150% +$1.67M ﹤0.01% 2438
2017
Q1
$1.29M Buy
+110,801
New +$1.29M ﹤0.01% 2771
2015
Q3
Sell
-97,285
Closed -$1.61M 3893
2015
Q2
$1.61M Buy
97,285
+25,216
+35% +$418K ﹤0.01% 2852
2015
Q1
$1.12M Sell
72,069
-27,395
-28% -$424K ﹤0.01% 2887
2014
Q4
$1.58M Buy
99,464
+5,489
+6% +$87K ﹤0.01% 2661
2014
Q3
$1M Buy
93,975
+93,955
+469,775% +$1M ﹤0.01% 2802
2014
Q2
$0 Buy
+20
New ﹤0.01% 5628
2013
Q4
Sell
-967
Closed -$5K 5391
2013
Q3
$5K Buy
967
+171
+21% +$884 ﹤0.01% 5232
2013
Q2
$5K Buy
+796
New +$5K ﹤0.01% 5129